Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DS-1040b in acute submassive pulmonary embolism
NCT02923115Phase 2Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jun 2016
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 8
01
Overview
Phase 2, randomised, double-blind trial in pulmonary embolism (PE) comparing DS-1040b with Placebo (2 arms). Primary endpoint: Number of Participants Experiencing Adjudicated Clinically Relevant Bleeding Events at Day 30. Started Jun 2016; status: completed.
02
Drugs
DS1040b
03
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT02923115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02923115.